-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Downgrades Twist Bioscience to In-Line, Raises Price Target to $102

Benzinga·07/06/2026 12:27:50
Listen to the news
Evercore ISI Group analyst Vijay Kumar downgrades Twist Bioscience (NASDAQ:TWST) from Outperform to In-Line and raises the price target from $66 to $102.